IP Library › Granted Patent US 7,968,681
Granted Patent B2
US 7,968,681 · App. 12/761,346 · Granted Jun 28, 2011

c-MET kinase binding proteins

Assignee: Amgen Mountain View, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,681
App. No.
12/761,346
Granted
Jun 28, 2011
Kind
B2
Abstract

Polypeptides comprising monomer domains that bind to c-MET, or portions thereof, are provided.

Claims (6)

1. An isolated polypeptide that binds to c-MET, wherein the polypeptide comprises the amino acids of SEQ ID NO:389 or a sequence that is at least 95% identical to the amino acids of SEQ ID NO:389.

2. The polypeptide of claim 1 , further comprising polyethylene glycol (PEG).

3. An isolated polypeptide that binds to c-MET, wherein the polypeptide comprises amino acids 1-38 of SEQ ID NO:389 or a sequence that is at least 95% identical to amino acids 1-38 of SEQ ID NO:389.

4. The polypeptide of claim 3 , further comprising polyethylene glycol (PEG).

5. A polynucleotide encoding the polypeptide of claim 1 .

6. A polynucleotide encoding the polypeptide of claim 3 .

Continuity (4)
Continuation 11155989 · Jun 17, 2005
Continuation In Part 10957351 · Sep 30, 2004
Continuation In Part 10871602 · Jun 17, 2004
Related Publication 20100292167A1 · Nov 18, 2010